1. Home
  2. KROS vs IMXI Comparison

KROS vs IMXI Comparison

Compare KROS & IMXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KROS
  • IMXI
  • Stock Information
  • Founded
  • KROS 2015
  • IMXI 1994
  • Country
  • KROS United States
  • IMXI United States
  • Employees
  • KROS 163
  • IMXI N/A
  • Industry
  • KROS Biotechnology: Pharmaceutical Preparations
  • IMXI Retail: Computer Software & Peripheral Equipment
  • Sector
  • KROS Health Care
  • IMXI Technology
  • Exchange
  • KROS Nasdaq
  • IMXI Nasdaq
  • Market Cap
  • KROS 558.9M
  • IMXI 302.5M
  • IPO Year
  • KROS 2020
  • IMXI N/A
  • Fundamental
  • Price
  • KROS $13.35
  • IMXI $10.14
  • Analyst Decision
  • KROS Buy
  • IMXI Buy
  • Analyst Count
  • KROS 13
  • IMXI 7
  • Target Price
  • KROS $20.63
  • IMXI $19.60
  • AVG Volume (30 Days)
  • KROS 620.1K
  • IMXI 331.1K
  • Earning Date
  • KROS 08-06-2025
  • IMXI 08-06-2025
  • Dividend Yield
  • KROS N/A
  • IMXI N/A
  • EPS Growth
  • KROS N/A
  • IMXI 1.60
  • EPS
  • KROS 0.11
  • IMXI 1.70
  • Revenue
  • KROS $214,713,000.00
  • IMXI $652,547,000.00
  • Revenue This Year
  • KROS $5,006.76
  • IMXI N/A
  • Revenue Next Year
  • KROS N/A
  • IMXI $3.03
  • P/E Ratio
  • KROS $123.16
  • IMXI $5.92
  • Revenue Growth
  • KROS 91657.70
  • IMXI N/A
  • 52 Week Low
  • KROS $9.12
  • IMXI $9.76
  • 52 Week High
  • KROS $72.37
  • IMXI $22.38
  • Technical
  • Relative Strength Index (RSI)
  • KROS 43.06
  • IMXI 35.45
  • Support Level
  • KROS $13.41
  • IMXI $9.80
  • Resistance Level
  • KROS $13.99
  • IMXI $10.49
  • Average True Range (ATR)
  • KROS 0.44
  • IMXI 0.37
  • MACD
  • KROS -0.07
  • IMXI -0.04
  • Stochastic Oscillator
  • KROS 9.84
  • IMXI 9.25

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

About IMXI International Money Express Inc.

International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

Share on Social Networks: